The global breast implants market is expected to reach US$ 2.37 billion by 2028; growing at a CAGR of 5.8% from 2021 to 2028. Breast implants are medical devices used to enhance the looks of the breasts in terms of shape, size and contour. Implants are prosthesis which contain gel like or fluid like components in a flexible sac. Though the surgery provides your desirable look, there are some complications to be thought about before heading to breast implants surgery. Best part about breast implants is that they are FDA approved for women above 22 years.Breast implants are made of silicon and saline. Silicone implants feel more natural tissues and are less likely to wrinkle however, they might spread in the breast and cause lumps.Saline implants get folded and is ruptured though they get absorbed in your body safely. Breast implants do not last forever, it lasts for 10-15 years and the patient may need another surgery later.
Urge to boost personal aesthetic appeal, hike in the prevalence of breast cancer, availability of wide range of products such as silicone and saline implants, advancements in the surgical techniques, urge to ameliorate breast size & shape especially among women, rising awareness and concerns about breast surgeries, availability of reimbursements, and conventional research & development are the major factors driving the global breast implants market.
Although the breast implants enhance the aesthetic appeal of the patient, they include certain complications like hardening of breast tissues, noticeable scars that shows no sign of fading, leaking of fluids and formation of lumps. These are the key factors which restrict the global breast implants market. Also, the slower rate of market growth in developing regions restricts the global breast implants market.
The growth in the surplus demand of silicone-based implants, product availability, advancements in the technologies, availability of skilled-surgeons and desire of bold and modest breasts are some of the factors providing opportunities to the market especially in the developed regions. North America currently dominates the global breast implants market where, silicone-based implants hold the largest market share in terms of revenue.
The ill effects of the implants, high cost of the available products, unawareness and myths about breast surgeries are some of the factors which challenge the global breast implants market.
The breast implants market is segmented on the basis of – Type, Shape, Application and End-User.The Type segment is further sub-segmented into silicone implants, form-stable implant, saline implant, and structured saline implant. Shape segment is further sub-segmented into round implants and anatomical implants. Application is further sub-segmented into reconstructive surgery, and cosmetic surgery, and end-user is sub-segmented into hospitals, cosmetology clinics, and others.
By region, the global breast implants market is segmented into North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA). The North America is further classified into U.S., Canada and Mexico. Europe is further segmented into Germany, U.K., France, Rest of Europe. Asia-Pacific is segmented into China, Japan, India, Rest of APAC. Currently, North America dominates the global breast implants market. Awareness in the people along with increase in the prevalence of breast cancer and its surgeries, and the urge to ameliorate the looks makes North America hold the largest market share among all the countries.
Some of the prominent factors in the global breast implants market are: AbbVie Inc. (Allergan plc), Establishment Labs SA, Groupe Sebbin SAS,Johnson & Johnson (Mentor Worldwide LLC), GC Aesthetics, Laboratories Arion, Polytech Health & Aesthetics GmbH and others.
Market Segmentation and Scope of Breast Implants Market